From: Renal dysfunction and prognosis of COVID-19 patients: a hospital-based retrospective cohort study
Cases, N (%) | Uric acid (μmol/L) | Urea nitrogen (mmol/L) | Creatinine (μmol/L) | Cystatin C (mg/L) | eGFR (mL/min) | |
---|---|---|---|---|---|---|
Gender | ||||||
Male | 92 (59.7) | 274.0 (218.0, 336.0) | 4.3 (3.6, 5.2) | 75.0 (66.0, 82.0) | 0.84 (0.75, 0.94) | 110.3 (97.0, 133.1) |
Female | 62 (40.3) | 201.0 (157.5, 245.0) ** | 3.2 (2.7, 3.6) * | 51.5 (44.0, 57.0) ** | 0.72 (0.64, 0.81) * | 142.2 (124.3, 175.3) ** |
Age | ||||||
<39 | 69 (44.8) | 253.0 (191.5, 306.5) | 3.6 (3.2, 4.3) | 65.0 (49.5, 78.5) | 0.76 (0.66, 0.87) | 133.5 (108.5, 181.6) |
40–59 | 68 (44.2) | 243.0 (186.0, 329.0) | 3.6 (3.0, 4.8) | 63.5 (53.0, 76.3) | 0.80 (0.71, 0.94) | 122.9 (103.4, 142.9) * |
>60 | 17 (11.0) | 288.0 (229.5, 347.0) *## | 5.3 (3.6, 6.9) *# | 72.0 (60.5, 87.0) *# | 0.90 (0.81, 1.39) **# | 105.4 (84.5, 121.1) ## |
Hypertension | ||||||
Yes | 22 (14.3) | 225.0 (195.0, 354.5) | 5.1 (3.1, 6.7) | 65.0 (52.0, 78.0) | 0.89 (0.75, 1.07) | 110.0 (94.3, 144.1) |
No | 132 (85.7) | 235.5 (178.3, 295.5) | 3.7 (3.1, 4.6)** | 66.0 (52.0, 77.0) | 0.80 (0.69, 0.89) * | 126.4 (103.2, 148.7) |
Diabetes | ||||||
Yes | 8 (5.2) | 327.0 (235.0, 372.0) | 6.3 (5.5, 10.6) | 72.0 (57.0, 108.0) | 0.99 (0.87, 1.54) | 106.2 (63.9, 133.0) |
No | 146 (94.8) | 234.0 (182.0, 298.0) ** | 3.7 (3.1, 4.6)** | 65.0 (52.0, 77.0) * | 0.80 (0.70, 0.90) ** | 126.0 (103.3, 150.1) * |
Other diseases | ||||||
Yes | 12 (7.8) | 227.0 (190.5, 344.5) | 4.5 (2.5, 6.0) | 69.0 (59.5, 76.8) | 0.90 (0.81, 0.94) | 109.8 (96.0, 129.8) |
No | 142 (92.2) | 236.0 (181.0, 298.0) | 3.7 (3.1, 4.7) | 65.0 (52.0, 77.8) | 0.79 (0.70, 0.91) | 126.5 (103.3, 150.1) * |